Podcasts about Beth Israel Deaconess Medical Center

We kicked off the program with four news stories and different guests on the stories we think you need to know about!Journey Forward's 15th Annual Casino Night – Thursday May 22nd – Journey Forward is a non-profit dedicated to bettering lives of those with paralysis. Christopher Knight – Actor (The Brady Bunch) & Host of This Year's Casino Night joined Dan to discuss the event.What is a Michelin Star and what does it take to earn one? The Michelin Guide (a guide rating the best restaurants) is coming to Boston. Restaurants inspectors have been deployed to Boston this year. Will Gilson - Chef/Owner of Cambridge Street Hospitality Group stopped by.New clues point to why colorectal cancer is rising in young people. Trisha Pasricha - Ask a Doctor columnist for The Washington Post & instructor in medicine at Harvard Medical School & directs the Institute for Gut-Brain Research at Beth Israel Deaconess Medical Center checked in with Dan.Patriot Week for Mass Fallen Heroes, a series of events honoring vets and Gold Star families leading up to Memorial Day. With Dan Magoon - Exec Director of Mass Fallen Heroes.Listen to WBZ NewsRadio on the NEW iHeart Radio app and be sure to set WBZ NewsRadio as your #1 preset!

Dr. Kelly Gwathmey interviews Dr. Corey Bacher from the University of Toronto, Dr. Charles Kassardjian from the University of Toronto, both in Toronto, Ontario, Canada. We also have Dr. Ruple Laughlin from the Mayo Clinic in Rochester, Minnesota, and Dr. Puspha Narayanswami from Beth Israel Deaconess Medical Center in Boston, Massachusetts. They will all be discussing recommendations for monitoring and managing glucocorticoid related systemic complications from the recently published: “International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Disease."

Aging (Aging-US) was proud to sponsor the Muscle Aging Science & Translation (MAST) Symposium, organized by the Aging Initiative at Harvard University on Friday, April 18, 2025. This important event brought together 350 participants—chosen from more than 1,300 applicants—including students, researchers, company founders, investors, and industry leaders. Together, they explored the latest research and innovations in muscle health and aging. The symposium reflected the journal's strong commitment to supporting collaboration across fields and advancing research in aging. -Key Highlights from the MAST Symposium- Clinical Research Perspectives on Frailty The symposium opened with a strong clinical session led by experts from top institutions: Dr. Roger Fielding (Tufts University and Boston Claude D. Pepper Older Americans Independence Center) and Drs. Douglas Kiel, Shivani Sahni, and Yi-Hsiang Hsu (Harvard Medical School and Beth Israel Deaconess Medical Center). The panel discussed key topics such as the biology of frailty, how bone and muscle health are connected, and the influence of genetics, diet, and exercise on staying strong as we age. By blending real-life patient care with the latest research, the speakers shed light on the challenges of sarcopenia—the gradual loss of muscle strength and mass that occurs with age—and the new scientific approaches being developed to improve treatment. Full recap - https://aging-us.org/2025/04/agings-ongoing-support-for-scientific-innovation-sponsoring-the-muscle-aging-science-translation-symposium/ Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts To learn more about the journal, please visit our website at https://www.Aging-US.com​​ and connect with us on social media at: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

We kicked off the program with four news stories and different guests on the stories we think you need to know about!Trump extends TikTok ban deadline by 75 days - predictions for potential outcomes, what the impact(s) would be on brands, creators and consumers? With Scott Sutton - CEO of Later (a marketing brand)The Fate of the Generals: MacArthur, Wainwright, and the Epic Battle for the Philippines - details the story of two World War II generals who both received the Medal of Honor through contrasting means of leadership. With Jonathan Horn - author and former White House speechwriter for President George W. Bush.Follow-up on the First Robot Assisted Live Liver Plant at Beth Israel Deaconess Medical Center. Dr. Martin Dibs – a surgeon involved in Zeller's procedure and director of Beth Israel's living liver transplant program.THE GOLF 100: A Spirited Ranking of the Greatest Players of All Time. With Michael Arkush – Author & Sportswriter who contributes to the NY Times & WaPo.Listen to WBZ NewsRadio on the NEW iHeart Radio app and be sure to set WBZ NewsRadio as your #1 preset!

Living with IBS-C often means silently dealing with more than just constipation. From missing social events to navigating daily stress and anxiety, the emotional toll can feel overwhelming. In this eye-opening episode of the Gastro Girl Podcast, host Jacqueline Gaulin talks with Dr. Sarah Ballou, Director of GI Behavioral Health at Beth Israel Deaconess Medical Center and Assistant Professor of Medicine at Harvard Medical School. Dr. Ballou shares insights from her groundbreaking research on what IBS-C patients are willing to sacrifice for symptom relief—and why the answer often lies in the gut-brain connection. We also explore the power of multidisciplinary care in IBS-C management. For many patients, the best outcomes come from combining medications, nutrition strategies, and gut-brain behavioral therapy—a team-based approach that treats the whole person, not just the symptoms. Dr. Ballou explains how GI psychologists work alongside gastroenterologists, dietitians, and other specialists to create personalized care plans that help patients feel heard, supported, and empowered. Whether you're living with IBS-C or supporting someone who is, this episode offers real hope, expert guidance, and practical strategies for managing symptoms without giving up the things you love. Sponsored by Ardelyx.

This episode is sponsored by: Set For LifeSet for Life Insurance helps doctors safeguard their future with True Own Occupational Disability Insurance. A single injury or illness can change everything, but the best physicians plan ahead. Protect your income and secure your future before life makes the choice for you. Your career deserves protection—act now at https://www.doctorpodcastnetwork.co/setforlife._______Curiosity isn't just a trait—it's a tool for better medicine. In this episode, Dr. Anthony Breu joins Dr. Bradley Block to explore how asking "why" transforms medical practice and patient care.They discuss the origins of the Curious Clinicians Podcast, born from social media "why" questions during the COVID era, and how it evolved into a platform for uncovering medical mysteries. Dr. Brau shares mind-blowing insights from the show like why elephants rarely get cancer, how furosemide works beyond diuresis, and the potential for oral insulin to revolutionize diabetes care. The conversation also covers practical takeaways, such as rethinking elevated lactate assumptions and wearing goggles to chop onions tear-free.With a mix of humor, science, and real-world applications, this episode is a masterclass in staying curious, challenging dogma, and bringing fresh perspectives to medicine—both in and out of the exam room.Three Actionable Takeaways:Stay Curious to Stay Sharp: Ask "why" about the things you see daily—whether it's a patient's response to meds or a biological oddity—to deepen your understanding and improve care.Challenge Medical Assumptions: Don't assume elevated lactate means hypoperfusion—consider beta-2 agonists like albuterol as a cause to avoid unnecessary treatments.Apply Podcast Lessons to Life: From wearing contacts to cutting onions without crying to appreciating furosemide's vasodilatory effects, small insights can enhance both personal and professional practice.About the Show:The Physician's Guide to Doctoring covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Anthony Breu is the Director of Resident Education at VA Boston Healthcare System and an Assistant Professor of Medicine at Harvard Medical School. A board-certified internist and hospitalist, he co-hosts the Curious Clinicians Podcast. With a BA in Bioethics and MD from Brown University, Dr. Breu trained at Beth Israel Deaconess Medical Center. His interests include medical education, clinical reasoning, and tackling intriguing medical mysteries.Website and Podcast:https://www.bumc.bu.edu/camed/profile/anthony-breu/https://curiousclinicians.com/About the Host:Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts the Physician's Guide to Doctoring podcast, focusing on personal and professional development for physicians.Want to be a guest? Email Brad at brad@physiciansguidetodoctoring.com or visit www.physiciansguidetodoctoring.com to learn more!Socials:● @physiciansguidetodoctoring on Facebook● @physicianguidetodoctoring on YouTube● @physiciansguide on Instagram and Twitter   Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance.

Medication safety remains a cornerstone of anesthesia practice with complex environments and high-stakes decisions requiring vigilant attention to prevent errors. This collaboration between APSF and OpenAnesthesia spotlights critical aspects of perioperative drug safety with practical insights from Dr. Juan Li, a cardiothoracic anesthesia fellow at Beth Israel Deaconess Medical Center.• Perioperative anaphylaxis requires immediate recognition of cardiovascular, respiratory, and cutaneous manifestations• Neuromuscular blocking agents and antibiotics represent common triggers for anaphylactic reactions• Preoperative assessment must include thorough allergy history, medication reconciliation, and identification of drug-drug interactions• Standardized drug concentrations, preparation methods, and equipment minimize medication errors• Technology integration through barcode readers and computerized decision support enhances safety• Pharmacy support with pre-mixed solutions and pre-filled syringes reduces preparation errors• Post-operative monitoring remains critical for catching delayed medication reactions• Safety culture should emphasize root cause analysis rather than punishment for medication errors• Implementation of standard protocols is essential for managing new medications with limited safety dataVisit APSF.org and Openanesthesia.org for detailed information and resources on medication safety in anesthesia practice.

Bioadhesive materials have the potential to support patient care in a number of ways, from wound healing to repairing the dura to assisting with leaks of cerebral spinal fluid. In this follow-up to our 2022 interview, Ben Freedman, PhD, of Beth Israel Deaconess Medical Center, shares technological advancements and discoveries made by his team over the past three years. Transcript: https://bit.ly/42btErk

Send us a textDr. Courtney Millar, Ph.D. ( https://www.marcusinstituteforaging.org/who-we-are/profiles/courtney-millar-phd ) is an Assistant Scientist at the Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, and Instructor in Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center.Dr. Millar is a research scientist devoted to improving health and well-being of older adults through dietary interventions and her current research aims to test the ability of anti-inflammatory dietary strategies that promote both physical and emotional well-being in older adults.Dr. Millar received her PhD in molecular nutrition at the University of Connecticut, where she developed a deep understanding of the relationship between dietary bioactive components and metabolic disease. Dr. Millar's post-doctoral fellowship focused on training related to conducting both nutritional epidemiological analyses and clinical interventions. The Hinda and Arthur Marcus Institute for Aging Research ( https://www.marcusinstituteforaging.org/ ) is focused on finding solutions to the most pressing challenges of aging, including Alzheimer's disease, dementia, osteoporosis, falls, frailty, and more.Important Episode Link - Tart Cherry Research Study - https://studies.buildclinical.com/bcfs001399-hsl-millar-79#CourtneyMillar #MarcusInstitute #AgingResearch #HebrewSeniorLife #HarvardMedicalSchool #BethIsraelDeaconess #MolecularNutrition #BioactiveCompounds #Atherosclerosis #Frailty #Inflammation #Senolytics #Dasatinib #Quercetin #Microbiome #TartCherryJuice #Alzheimers #Dementia #Lipid654 #Healthspan #Geroscience #Longevity #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Dr. Aditi Nerurkar is a Harvard physician, nationally recognized stress expert, and author of “The 5 Resets: Rewire Your Brain and Body For Less Stress and More.” She is also an in-demand multi-media personality, high profile medical correspondent, internationally renowned Fortune50 speaker, and podcaster. Uniquely fulfilling her original career ambition to be a journalist, Dr. Nerurkar has been featured in The Wall Street Journal, The Washington Post, Oprah Magazine, Architectural Digest and Elle – in addition to being a columnist for Forbes and writing for The Atlantic. She has made more than 300 appearances as a medical commentator on MSNBC, CNN, NBC, ABC and CBS News; and has spoken at the “Forbes 30 Under 30 Summit” and Harvard Business School Women's Conference. Dr. Nerurkar also co-hosts the popular and influential “Time Out: A Fair Play Podcast” with New York Times best-selling author Eve Rodsky. Dr. Nerurkar's first brush with intense media demand came in 2011 – when she was a Research Fellow at Harvard – with the publication of a study she conducted in the Journal of the American Medical Association (JAMA) titled: “When Conventional Medical Providers Recommend Unconventional Medicine”; followed by her first interview with Diane Sawyer on World News Tonight, and attention from NPR.Dr. Nerurkar's expertise on stress comes from working with thousands of patients throughout her years as a primary care physician and director of an integrative medicine program at Harvard's Beth Israel Deaconess Medical Center, from 2012-2020. She is now a lecturer at Harvard Medical School in the Division of Global Health & Social Medicine and serves as the Co-Director of the Clinical Clerkship in Community Engagement. She has also worked in global public health at a World Health Organization collaboration center in Geneva, Switzerland. Though she entered Barnard College at Columbia University with an eye toward studying journalism, Dr. Nerurkar's family DNA all but dictated a future in medicine. In India, her grandfather was a surgeon and her grandmother, one of only three women in her medical school, was an OB/GYN. She was raised by her grandparents in Mumbai until the age of six while her parents were in the U.S. studying medicine themselves. She then came to the States, where she grew up outside of Philadelphia, Pennsylvania.  Even as she thrived as a researcher and practicing physician, she developed a love for media and health communication and knew she would eventually use her creative and journalistic talents to facilitate action. Her first published article in The Huffington Post, “Medication or Meditation: Which Should You Choose?” launched this side of her career. During the pandemic, her speaking career took off as a speaker with The Leigh Bureau Speaking Agency.  Topics covered in this episode:Food choices and HealthImportance of SleepMindfulness and MeditationDigital Detox and Social MediaExercise Building ResiliencePersonal Well-Being JourneyHabits for a Healthy LifeSelf-CareStrategies for Stress ReliefBalancing Information ConsumptionCultivating Self-CompassionOvercoming BurnoutHuman Connection and StressReferenced in the episode:The Lindsey Elmore Show Ep 216 | Pulling Back The Curtain: How Medicine is Really Practiced in the U.S. | Otis BrawleyTo learn more about Dr. Aditi Nerurkar and her work, head over to https://www.draditi.com/____________________________________________________________________________________________________________________We hope you enjoyed this episode. Come check us out at https://www.spreaker.com/show/the-lindsey-elmore-showBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.

On today's episode of The Wholesome Fertility Podcast, I am joined by the incredible Dr. Alice Domar, a pioneer in the field of mind-body medicine and a leader in reproductive health psychology. Dr. Domar shares insights from her decades of research and work with patients experiencing infertility, diving deep into the emotional and physical toll of fertility challenges and how stress can impact reproductive outcomes. We discuss the groundbreaking research that links stress reduction to increased fertility success rates, the importance of patient-centered care, and how mind-body practices can transform the fertility journey. Dr. Domar also shares her thoughts on spirituality, the power of connection, and how fostering a sense of belonging can help patients navigate the emotional rollercoaster of infertility. This episode is packed with valuable insights and hope for anyone on the fertility journey. Be sure to tune in as you won't want to miss this eye-opening and inspiring conversation! Key takeaways: Stress significantly impacts reproductive outcomes, and reducing stress can improve success rates in fertility treatments. Research shows infertility patients often experience anxiety and depression levels similar to those with major illnesses like cancer or heart disease. The brain and body are constantly connected, and managing stress through mind-body strategies can positively influence fertility. Connecting with spirituality or a higher power can help individuals cope with the emotional challenges of infertility. Isolation is common for those facing infertility, but connecting with support groups or programs can provide invaluable relief and healing. Cutting-edge research using physiological devices to measure stress in real-time may revolutionize how stress is addressed during fertility treatments. Empathy, connection, and compassionate care are essential for improving the patient experience and outcomes. Guest Bio: Alice “Ali” Domar, Ph.D. is a pioneer in mind-body medicine, focusing on the relationship between stress, medical conditions, and lifestyle habits. She is Chief Compassion Officer at Inception Fertility, part-time associate professor at Harvard Medical School, and senior staff psychologist at Beth Israel Deaconess Medical Center. Dr. Domar is the author of Conquering Infertility and Finding Calm for the Expectant Mom and serves on advisory boards for Parents Magazine, Resolve, and Easy Eats. Her work has been featured in Redbook, Health, and BeWell.com. Websites/Social Media Links: https://www.instagram.com/inceptionfertility/ https://inceptionfertility.com/about-us/our-team/ https://www.preludefertility.com/  

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Mujtaba Mubashir, CTSNet JANS editor and surgical resident at Beth Israel Deaconess Medical Center, about being a JANS editor. They discuss what JANS is, their favorite part about JANS, and their favorite articles. They also explore highlights from the 61st Society of Thoracic Surgeons Annual Meeting, including how to manage chest tubes after surgery and their favorite part of the meeting. Joel also shares details about his recent trip to Accra, Ghana, for the first Pan-African Society for Cardiothoracic Surgery (PASCaTS) and Global Heart Forum summit. He discusses different organizations, including Emergency NGO Sudan and Every Heartbeat Matters, examines various mission models, and discusses patients and surgeons he met at the summit.   Joel also reviews recent JANS articles on moving toward standardization in robotic lung transplants, how single lung transplantation is safe when the other lung is declined, perioperative outcomes and survival of modified subxiphoid video-assisted thoracoscopic surgery thymectomy for T2-3 thymic malignancies, and robotic thoracic surgery using the single-port robotic system.  In addition, Joel explores how to replace a severely calcified mitral valve, preoperative management of patients at high risk for recurrent laryngeal nerve injury during esophagectomy, and a presentation from the 10th Annual International Coronary Congress, “Maintaining CABG as a Gold Standard in 2024.” Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) Towards Standardization in Robotic Lung Transplant: A Novel Approach in Minimally Invasive Thoracic Surgery  2.) Single Lung Transplantation Is Safe When the Other Lung Is Declined  3.) Perioperative Outcomes and Survival of Modified Subxiphoid Video-Assisted Thoracoscopic Surgery Thymectomy for T2-3 Thymic Malignancies: A Retrospective Comparison Study   4.) Robotic Thoracic Surgery Using the Single-Port Robotic System: Initial Experience With More Than 100 Cases  CTSNET Content Mentioned  1.) How to Replace a Severely Calcified Mitral Valve  2.) ICC 2024 | Maintaining CABG as a Gold Standard In 2024  3.) Preoperative Management of Patients at High Risk for Recurrent Laryngeal Nerve Injury During Esophagectomy  Other Items Mentioned  1.) Utter Shock as Unreel Robotics Stuns the World of Surgery With the World's First Fully Autonomous Soft Tissue Surgical Robot   2.) Career Center   3.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Are you worried about whether your teen is just moody or actually struggling with depression? Do you wonder how much of their emotional ups and downs are connected to digital media? In this episode of Power Your Parenting: Moms with Teens, host Colleen O'Grady sits down with Dr. Meredith Gansner, a child psychiatrist and researcher, to discuss the rising rates of teen depression in the digital age. Together, they explore how social media, online interactions, and excessive screen time contribute to adolescent mental health struggles. Dr. Gansner shares insights from her research and her new book, Teen Depression Gone Viral, highlighting how parents can recognize signs of depression, differentiate between typical teen emotions and clinical concerns, and take proactive steps to support their child's well-being. They also tackle the difficult topic of suicidal ideation, how parents can navigate these conversations, and the importance of maintaining open communication while setting digital boundaries. Dr. Meredith Gansner is an instructor of psychiatry at Harvard Medical School and attending child psychiatrist at Boston Children's Hospital. After completing medical school at Rutgers New Jersey Medical School, she completed her psychiatry residency at Beth Israel Deaconess Medical Center and Brigham and Women's Hospital and a fellowship in child psychiatry at Cambridge Health Alliance. Her research explores high-risk digital media use in adolescents and managing high-risk digital media habits. She is an active member of the American Academy of Child and Adolescent Psychiatry media committee, has written articles about mental health and digital media for The Psychiatric Times,The Boston Globe, and Slate magazine. Key takeaways from this conversation include the importance of observing your teen's level of functioning rather than just their emotions, understanding that social media is not inherently harmful but can be risky without guidance, and remembering that parents need support too—caring for yourself helps you better support your teen. With expert advice and practical strategies, this episode empowers moms to feel more prepared to guide their teens through the challenges of growing up in a digital world. Learn more about Dr. Gansner at https://www.childrenshospital.org/directory/meredith-gansner Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode, recorded live at the Becker's Healthcare 12th Annual CEO + CFO Roundtable features Ruben Azocar, VP for Perioperative Services at Beth Israel Deaconess Medical Center. Here, he shares his perspectives on addressing cybersecurity risks, leveraging artificial intelligence for operational efficiency, and tackling financial challenges in healthcare. He discusses strategies for improving patient care while managing costs, and how AI can support the revenue cycle and enhance the use of operating rooms.In collaboration with R1.

Join us for an empowering and insightful conversation as Dr. Jennie Berkovich sits down with Dr. Amy Comander, a leading breast oncologist and advocate for patient-centered care. In this episode, Dr. Comander shares her expertise on the latest advancements in breast cancer detection, treatment, and survivorship. Discover how personalized medicine and multidisciplinary care are revolutionizing outcomes for breast cancer patients. Dr. Comander also delves into the critical role of lifestyle medicine—including exercise, nutrition, and mindfulness—in promoting healing and resilience. With her unique perspective as a passionate runner and physician, Dr. Comander draws inspiring parallels between running and the cancer journey, offering hope and practical advice for patients and their families navigating a diagnosis. Whether you're a healthcare professional, patient, or advocate, this episode will leave you informed, inspired, and ready to run the race toward better cancer care. Don't miss it! Dr. Amy Comander specializes in the care of women with breast cancer.  Dr. Comander is Medical Director of the Mass General Cancer Center in Waltham, where she also serves as Director of Breast Oncology and Cancer Survivorship at the Mass General Cancer Center in Waltham and at Newton Wellesley Hospital. She is an Instructor in Medicine at Harvard Medical School. She received her undergraduate degree and a master's degree in Neuroscience at Harvard University. She received her medical degree at Yale University School of Medicine. She completed her Internal Medicine residency training and Hematology-Oncology fellowship training at Beth Israel Deaconess Medical Center and Harvard Medical School. She is board certified in Hematology and Medical Oncology, and she is a Diplomat of the American Board of Lifestyle Medicine. _________________________________________________ Sponsor the JOWMA Podcast! Email digitalcontent@jowma.org Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

In this episode of the Pediatric and Developmental Pathology, our hosts Drs. Mike Arnold (@MArnold_PedPath) and Dr. Jason Wang speak with Dr. Philip Katzman of the University of Rochester Medical Center and Jonathan Hecht of Beth Israel-Deaconess Medical Center about their article in Pediatric and Developmental Pathology: Triaging and Evaluation of Products of Conception in Abortions and Post-Partum Hemorrhage Hear their tips for trainees about handling POC specimens, and what is different about first trimester specimens than term placentas.   Featured public domain music: Summer Pride by Loyalty Freak  

Dr. Kate Lund is a clinical psychologist.  She shares how a medical condition in her youth taught her empathy, her clinical focus on adaptation, the human side of injury, the importance of hope, maximizing potential in one's unique context, her focus on parenting, strategy to help more people, and focusing on the possibilities.Dr. Kate Lund is a licensed clinical psychologist of 15 years, peak performance coach, best-selling author and TEDx speaker. Her specialized training in medical psychology includes world-renowned Shriners Hospital for Children, Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center, all of which are affiliated with Harvard Medical School.  Dr. Kate uses a strengths-based approach to help her clients improve their confidence in school, sports and life while helping them to become more resilient and reach their full potential at all levels.Outside of her work, she enjoys spending time with her husband and twin boys exploring the outdoors of the Pacific Northwest and she can often be found on the golf courses.https://www.katelundspeaks.com/The Optimized Mind - Listen on Apple Podcasts: https://podcasts.apple.com/us/podcast/the-optimized-mind/id1648306501?i=1000581545932

This segment of Cancer Registry World highlights the vital role that regional cancer registrar organizations play in supporting the oncology data specialist community. Sheila Malacaria, ODS-C, Manager of the Cancer Registry at Beth Israel Deaconess Medical Center in Boston, and Ren Garcia, ODS-C, Oncology Data Manager and Registry Quality Analyst at AMN Healthcare in Portland, ME, both serve in leadership roles within the Cancer Registrars Association of New England (CRANE). They share insights on how regional associations fulfill the educational and networking needs of ODS professionals, fostering growth and collaboration across the field.

In this episode, podcast hosts Dr. Josh Roshal, Dr. Darian Hoagland, and Dr. Maya Hunt discuss the ins and outs of professional development time (PDT) and professional identity formation (PIF) during surgical training. Joined by insights from fellow CoSEF members, the team dives into key topics such as mentorship, timing, and making the most of this critical phase in residency. From rapid-fire tips to personal reflections, this episode offers a wealth of advice for trainees considering their PDT and PIF.. Episode Hosts: –Dr. Josh Roshal, University of Texas Medical Branch, @Joshua_Roshal, jaroshal@utmb.edu –Dr. Darian Hoagland, Beth Israel Deaconess Medical Center, @DHoaglandMD, dlhoagla@bidmc.harvard.edu –Dr. Maya Hunt, Indiana University, @dr_mayathehunt, mayahunt@iu.edu –CoSEF: @surgedfellows, cosef.org Guests:  -Dr. Ariana Naaseh, Washington University in St. Louis, @ariananaaseh, a.naaseh@wustl.edu -Dr. Colleen McDermott, University of Utah, @ColleenMcDMD, Colleen.McDermott@hsc.utah.edu -Dr. Shahnur Ahmed, Indiana University, shahme@iu.edu -Dr. Xinyi “Cathy” Luo, Tulane University, @DoctorSoySauce, xluo@tulane.edu -Dr. Ananya Anand, Stanford University, @AnanyaAnandMD, aa24@stanford.edu References: Smith SM, Chugh PV, Song C, Kim K, Whang E, Kristo G. Perspectives of Surgical Research Residents on Improving Their Reentry Into Clinical Training. J Surg Educ. 2024 Nov;81(11):1491-1497. doi: 10.1016/j.jsurg.2024.07.005. Epub 2024 Aug 31. PMID: 39217679. https://pubmed.ncbi.nlm.nih.gov/39217679/ Kochis MA, Cron DC, Coe TM, Secor JD, Guyer RA, Brownlee SA, Carney K, Mullen JT, Lillemoe KD, Liao EC, Boland GM. Implementation and Evaluation of an Academic Development Rotation for Surgery Residents. J Surg Educ. 2024 Nov;81(11):1748-1755. doi: 10.1016/j.jsurg.2024.08.015. Epub 2024 Sep 23. PMID: 39317122. https://pubmed.ncbi.nlm.nih.gov/39317122/ Gkiousias V. Scalpel Please! A Scoping Review Dissecting the Factors and Influences on Professional Identity Development of Trainees Within Surgical Programs. Cureus. 2021;13(12):e20105. doi:10.7759/cureus.20105 https://pubmed.ncbi.nlm.nih.gov/35003955/ Rivard SJ, Vitous CA, De Roo AC, et al. “The captain of the ship.” A qualitative investigation of surgeon identity formation. Am J Surg. 2022;224(1 Pt B):284-291. doi:10.1016/j.amjsurg.2022.01.010 https://pubmed.ncbi.nlm.nih.gov/35168761/ Irby DM, Cooke M, O'Brien BC. Calls for reform of medical education by the Carnegie Foundation for the Advancement of Teaching: 1910 and 2010. Acad Med J Assoc Am Med Coll. 2010;85(2):220-227. doi:10.1097/ACM.0b013e3181c88449 https://pubmed.ncbi.nlm.nih.gov/20107346/ Veazey Brooks J, Bosk CL. Remaking surgical socialization: work hour restrictions, rites of passage, and occupational identity. Soc Sci Med 1982. 2012;75(9):1625-1632.doi:10.1016/j.socscimed.2012.07.007 https://pubmed.ncbi.nlm.nih.gov/22863331/ Cruess RL, Cruess SR, Boudreau JD, Snell L, Steinert Y. A schematic representation of the professional identity formation and socialization of medical students and residents: a guide for medical educators. Acad Med J Assoc Am Med Coll.2015;90(6):718-725.doi:10.1097/ACM.0000000000000700 https://pubmed.ncbi.nlm.nih.gov/25785682/ Huffman EM, Anderson TN, Choi JN, Smith BK. Why the Lab? What is Really Motivating General Surgery Residents to Take Time for Dedicated Research. J SurgEduc.2020;77(6):e39-e46.doi:10.1016/j.jsurg.2020.07.034 https://pubmed.ncbi.nlm.nih.gov/32768383/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

Host Dr. Davide Soldato and guests Dr. Suzanne George and Liz Salmi discuss their JCO article "Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality" TRANSCRIPT TO COME Dr. Davide Soldato: Hello and welcome to JCO's After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, Medical Oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by JCO authors Liz Salmi, Researcher and Patient Advocate, and by Dr. Suzanne George, who works as a Medical Oncologist at the Dana-Farber Cancer Institute where she acts as the Chief of the Division of Sarcoma. She is also Associate Professor of Medicine at Harvard Medical School. Today, we are going to discuss with Suzanne and with Liz the article titled, “Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality.” So thank you for speaking with us, Suzanne, Liz. Liz Salmi: Thanks for having us. Dr. Suzanne George: Yes, thanks. Dr. Davide Soldato: I just want to make a brief introduction because I think that the concept of patient partner research is very wide and I'm not sure that all of the readers of JCO really have a deep understanding because I imagine that there are a lot of ways we can involve patient and patient advocates in the research process. And so I was wondering if you could give us a little bit of an introduction about the concept. Dr. Suzanne George: Sure. I think the point that you raise is really important because there are many terms that are used, patient-partnered research, patient advocacy, but I don't think that there's a single definition as to what that actually means. In the context of our work, we've sort of summarized our experience through something called the PE-CGS or the Participant Engagement and Cancer Genome Sequencing network. And in that project, which is a Moonshot funded network, the intention is to have participants in research be true partners working with traditional academic research teams in order to develop networks specifically focused on cancer genomics. So what we've done, every center is a little bit different in the network, but we're really having research participants not just act, but really work on the research team from the beginning of the project inception all the way through the research project. Liz Salmi: What brings me to the PE-CGS network is my 17 years experience as a person living with a low grade glioma, brain tumor or brain cancer and involving patients in the co-design of research is super critical because patients bring unique lived experiences that can shape research questions, study designs and outcome measures in ways researchers might not anticipate. And we're finding this through our network. So through my work, including my patient experience and brain tumor focused study designs, I've seen firsthand that patient insights can drive more practical implementations that ultimately benefit both patients and the researchers. And so the particular project I work on in the network, we've got like five different arms and different groups of cancer types that are being represented, so I'm basically focusing on the OPTIMUM study around how brain tumor patients can help in this study design. So in this project I serve as not just a participant in the research, but also as a patient co-investigator. Dr. Davide Soldato: That is very interesting. And I think that we really captured the essence of patient-partnered research by having both of you here talking with us about the PE-CGS. And the second question that I wanted to ask is: I really think that the network focuses on something that is quite important right now and currently in medical oncology - so cancer genome sequencing, access to novel therapies - and I think that it's really challenging to imagine a way in which we can really get our patient and get patient advocates to help us designing new trials who are looking into this. And I just wanted to know, do you think that there is something that is particularly challenging when we are speaking specifically about cancer genomics and access to this type of drugs that are targeting specific molecular alteration? Because I think that in general it might be a little bit easier, maybe I'm biased on this, so you can also tell me if I'm wrong, but I think that it's a little bit easier when we are trying to design, for example, behavioral intervention or things that are more commonly found in oncology and a little bit more complicated when we are speaking about genomics. Dr. Suzanne George: So I think that's part of what this network is trying to address, which is really what are the barriers and the opportunities around cancer genomics from the patient perspective and how do we make sure that that perspective is included as we're thinking about study design and inclusion? As Liz mentioned, this network has five different networks within the network, five different centers, and each center is slightly different with the population that it engages with. And so there's diversity there in terms of reaching out to different patient communities and partner communities around potential barriers for genomics research. I think one of the things though that we're finding across the network is that people want to be part of this work. People that have a lived experience of cancer want to help move the field forward. And what we ended up writing about was some of the barriers that get in the way of that. It's awesome to have people like Liz that are like all in and then there's people who are on the other end of the spectrum that want to share their information to help move the field forward around genomics, but then there's all these barriers at the systems level that get in the way of that. So I think that that's one of the challenges we're trying to overcome and learn about across the network. Liz Salmi: Yeah, I think I bring this really interesting, I can't say I'm really interesting, but I think I bring this really niche perspective. Not only am I a person living with a brain tumor and I'm a co-investigator but also like a participant in this study. I also, in my day job, I'm an investigator as part of the director of communications and patient initiatives on the OpenNotes lab at Beth Israel Deaconess Medical Center. And our lab really focuses on how open, transparent communication between doctors and patients improves care. And that's been going on for longer than I've been around on our team. But what I bring to that lab is I focus on engaging both patients and clinicians in spreading the awareness about the power of how easy access and transparent communication, access to information across healthcare settings helps patients feel more involved and informed in their care.   And I work specifically, it's a really niche area. I work on projects that aim to expand access to notes and test results in diverse care settings, really helping tailoring initiatives so that various patient communities can understand how they can be involved in these types of research projects. Ultimately that's what brought me into this space. I might be one of the first generation of patients that actually starts helping co-design studies on things like this. And I think that across a lot of healthcare settings cancer is really what we're focused on. But patients are now increasingly being involved as research collaborators. And there's many different funding institutions such as the NCI but also PCORI they now mandate that funders reflect a shift towards more patient centered research frameworks. So it's like the PE-CGS network isn't the only group that's being funded to do research in this way. And I think other investigators, even outside of the cancer space, but specifically in cancer, need to learn how to do research in this way. Dr. Suzanne George: Yeah, I agree. And I think the other thing that we need to do is if people want to participate and that participation in many of these networks has to do with record sharing and data sharing, the system needs to accommodate that. If people want to share their information in order to allow research to be performed, then we need to make sure that that can happen, and that it's not that the institution systems don't connect with someone else's systems or that you to pay X, Y and Z dollars for the data to go A, B and C, or that some places are on this EHR and some places are on that EHR and so, sure, you can share it, but you have to go through all of these hurdles in order to make it happen. When a patient signs a consent form that says, “I want my data to be used,” we as an investigator community, we owe it to that patient to make sure that their information is being part of the data set that will be used for learnings. And that's part of what we wrote about, is the lots of behind the scenes things that just get in the way and that we need to work towards improving. Liz Salmi: Both Suzanne and I are really passionate about this stuff. And as a person living with a brain tumor for the last 17 years, I'm a chronic research participant. I always, always, am really curious. I'm like, “Yes, let me contribute my data. Whether that's electronic health record data or maybe I'm being interviewed about certain aspects of the cancer care experience.” And the one thing that bummed me out for like the first 10 years of being this chronic research participant is I would enroll in things, I'd be interviewed for things, I'd fill out these surveys and then I never heard anything about what happened with that information and that time I spent. And people would send me like a $10 gift card to Amazon, like, “Thanks for participating,” but really what I wanted to know is like, did you do anything with that? How did that inform things? So that really annoyed me to the point where I was like, I'm just going to be part of the research process and really figure out how we share that information back to everybody who had spent so much time. And so my participation in this space is like, “Let's change it. Let's give people information back.” And now I know it takes a really long time to have a finding that could be published somewhere that we then get it back. But closing the loop on the communications gap is something I'm really passionate about. Dr. Davide Soldato: Do you think that we are changing a little bit this perspective? I feel like we are getting a little bit better in creating patient communities of patients who are included in specific clinical trials. And then we do the effort of creating a community, of keeping people really involved with the research that they are participating in. I think that we are not quite there yet, but I think that we are making some kind of steps in that direction. For example, trying also to inform patients to participate in the study when the publication that is related to that specific study comes out. What is the benefit? What have we discovered? I think that we are not quite there yet. There is a lot of room for improvement, particularly in the way I think we communicate these to patients who participated in research. But I have the impression that we are making some steps forward. So I don't know. Do you share the same thoughts? Liz Salmi: So Dr. George talked about the PE-CGS network and then there's five different cancer types being studied. So the thing I can reflect on is what we've done in the, this is a really long acronym but, Optimizing Molecular Characterization of Low Grade Glioma. Say that 10 times fast. So our particular group is people who donate tissues about their brain tumors. We're really collecting data from people with multiple brain surgeries over time, which is really complicated and to make that process easier. And then once those tissue samples are stored somewhere, studying that information about what changes in the brain tumors over time and then also giving those results back to people so they can take that research level data and bring it back to their neuro oncology team and say, “Hey. Here's what I found out, “and having a conversation. So, this is a long multi touch point study and in order to do that, to even make that possible is the individual patients need to understand what's in it for them. They're donating precious tissue in order to make the research process work. And so in order to do that, it's not just the investigators saying, “Hey. Give us your brain tissue, peace out.” It is we have a whole research advisory council of people living with these particular tumor types who help us co-design how do we do that outreach, how do we explain why this is important, or how do we message the importance of this work so they understand,“Oh, this is what's in it for me and this is what's in it for other people like me.” And from there then with that process, which again I mentioned, all of these multi-step processes, once we're able to understand how patients want to hear that information, what's in it for them, then we bring it back to like those bench scientists, investigators going, “Okay. And here's how this workflow should work for the patients,” and design everything around the patient experience before we even care about what's happening from the scientist researcher perspective. Dr. Suzanne George: I agree. I think to your point, I think the fact that we're all here today talking about this is just like you said, is that we are making progress, right? Like we're even here having this conversation. Just like you said, I think there's opportunities to improve and further refine the communication and the involvement back in the patient community. When I think- if I put on my clinical investigator hat, I'm very involved in PE-CGS, but my primary research interest historically has been clinical trials and drug development. And I think that our approach in communicating results back has just not been consistent. But I do think that there's opportunities, just like you said, to provide summaries of information to loop back. I don't think that we've completely solved: What do we do? How do we provide information back to loved ones of patients that may no longer be alive that participated? How do we provide information to people who maybe we don't have their contact information? What if we lose track of them? How do we also make sure that we give people the choice to know? Do you want to know about this or would you rather just participate and then give space to that research? Because maybe that's how people's best for them. So I think that you're right, we're making progress, but I think that there's also a lot more that we can do. So I'm glad we're talking about it. Dr. Davide Soldato: How much do you think that directly involving patients in this process, like asking them directly and co-designing the trial from the very beginning and understanding the level of information? This might also be another question inside of the question. So first, how much co-designing this type of research helps, and then do we also need to further refine at that level of communication, different communication depending on the level of information that different people want to have? Because I think that that's another level of complexity that we need to work towards at a certain point. We need to work on that first level of giving back the information. But then I think that there is also the other point of providing the information and information that should also be probably adapted to the cultural belief of different patients, to the ethnicity or to whatever cultural background or social background or whatever they may place their most interest in. Dr. Suzanne George: So I think that you're 100% right on all of those points. I think those are all topics that need to be considered. We may be able to get to a certain degree of granularity around those communication points, but on the other hand, we also want to be able to communicate broadly and accessibly as possible. One of the interesting things about PE-CGS, as Liz was mentioning, is each of the five centers has a slightly different focus. For example, one of the centers is focused on American Indians and Tribal Nations, and the communication practices coming out of that center are really unique and really very special and something that's been really, I think for me, very fascinating to hear about. Because to your point, like, just the strategy and what's considered appropriate is just different. I think if we hope to build a research world where our research participants and research data come from a broad swath of the population that really represents the population, the only way that we're going to be able to do that is find ways that bring meaning across the population as well. And that may be different based on where people are coming from and where people are at in their own journeys and in their own lives. But it's on us to be open to that and like to hear that, so we can do the right thing. Dr. Davide Soldato: And I think that this is one of the objectives of the PE-CGS, really trying to bring this type of research participation to really diverse and underrepresented populations, not only in terms of cultural background, but I also think about different types of tumors. Like Liz was referring about brain cancer or low grade glioma, which is a very niche population. And I also think about sarcomas, for example, the degree of variability that we have in that specific type of disease is such that we really need to probably find different ways to communicate also inside of this diversity in terms of single patient and experiences, but also in terms of single diseases. You were speaking a little bit before about the fact that the manuscript is really on the barriers that we would need to identify and then to change to make this system a reality. We were talking a little bit about consenting information and consenting the sharing of information, and I think that you make a very interesting point about the consent process when we are designing research. Could you give a little bit of your impressions about giving informed consent? What we need to change, how can we improve? Dr. Suzanne George: The bottom line is the consent process needs to be simple, clear, and transparent. And sometimes I feel, because the traditional way that we've always gone about consent is frequently consent is as it should be in many ways. These consent forms are developed from a regulatory framework. What are we required to do to consent and how do we meet those requirements? Sometimes that becomes directly at odds with how do we do this simply, clearly and transparently? And I think as a research community, we have to be able to find a common ground there. That has to include regulatory requirements, that has to include IRBs. When we think about consents and work with our patient communities on this, everybody agrees the consents need to be more simple, except the IRB or maybe the IRB agrees, but it's this tension between how do we make it simple, clear and transparent and not get so bogged down in the regulatory that we lose that intent. Liz Salmi: It's complicated. As a person, I mentioned, I'm a chronic research participant living with a brain tumor for 17 years. I remember enrolling in studies and seeing things that are just so complicated. I'm like, “Well, I'm just going to sign off.” I imagine somewhere somebody who knew more than me said, “I should just fill out this thing.” And then as I switched to the research world, I spent more time digging into, “Wow, this is a really complicated consent,” versus, “This is a really streamlined consent and I love this.” And throughout my work with Dr. George and others on the PE-CGS network, an example of a good consent that's easy for people to understand is what the NIH All Of Us research project did, where they're trying to get a million people, more than that, signed up to be in this longitudinal study. And their consent is to go to their website and they have a whole bunch of short YouTube videos. There's a kind of like a quiz involved and they're animated, they have multiple languages involved. And I signed up for that study and I was like, “This is a beautiful consent.” And it's a very plain language. And more consents like that. If you're looking for a good example, go there. I have not been paid by them in any way. I'm a participant in their study. I'm not sure if you guys and your listeners are aware, but there was I think, October 19th of this year or 2024, there was a special communication published in JAMA on an update on the Helsinki Principles for Medical Research involving human participants. And what they're saying is an ethical update is patient engagement in research, which emphasizes the need for continuous, meaningful engagement with research participants and their communities throughout the research life cycle, before, during and after studies. And so this is what we're talking about here. And it's now been embedded in these updated principles. Dr. Suzanne George: That's really great and I agree with you. I think the All Of Us consent process is very accessible. It feels like you can understand it. But the other thing is that, again, I also am not directly involved with All Of Us, but the other thing about it is that they also have a high-touch way to consent where they have navigators and people that will go into communities in a very resource intensive way. So there's all different ways to go about it. We need to find a way that we can balance the complexity around regulatory and the simplicity and transparency that we need in cancer research. Dr. Davide Soldato: Do you think that in terms of patient engagement we are doing better in academic sponsored research compared to sponsored research? A little bit of a provocative question maybe. Dr. Suzanne George: I think that's a really interesting question. I think this idea of participant engagement and involvement is being infused across the research community. And in part, the FDA has prioritized it as well. I think the industry sees the FDA prioritizing this as well. And I think that there are many companies that are involving participant and advocacy communities in different ways in the study design, in the study process early on. So I think it's happening. Liz Salmi: I'll be spicy. I've been a participant, I've been an investigator, co-investigator on studies and I have been reached out to often by pharma of, “Hey Liz, brain tumor patient advocate, would you be kind of like the poster child of our study or be involved in that way?” And I personally want to have no work in that space. I have no interest. However, I am approached, and other people living with cancer have been approached, by industry about lending their likeness or being commercials. And I don't think there's enough education to patient advocates of what that necessarily means, pros and cons. But I also can't speak on behalf of all of the patient advocates who might want to see that's a way that they could lend their voice and advance research. I personally think that there needs to be more involvement from the academic side of creating spaces where patients can be involved in the co-design of research and they also get compensated for their time fairly at the same level or some version of it in a way so they don't just jump to the pharma side of things. But that's an opinion that I have. Opinions. Dr. Suzanne George: I think it's really interesting the point that you make about providing more awareness or information about what it even means to do these things from a patient side. I certainly don't know that side as well, but I do see, often, the term patient advocate used very frequently in many different contexts that mean many different things. And I think that there's an opportunity there for understanding more about what that really means and what it can mean. Liz Salmi: Yeah. We want to involve patients, we want to do patient engagement. The BMJ or the British Medical Journal, have this new policy in place for patients as reviewers of research. And what I find interesting with the BMJ is they also ask patients to declare their conflicts of interest. So this is kind of a new space. If you're involved in patient research or perhaps working with pharma, patients, if you're involved at that level, should also be declaring their conflicts of interest if they're getting paid by a pharma. Or do I have a conflict now that I'm doing this cool ASCO podcast? Maybe. But do we want to overburden patients with tracking all this information? So it's a new world. The more we have access to information, the more we share information, the more we can read studies and we co-design, there's a new space I think over the next 5 to 10 years where how do we define this in a transparent way. Dr. Suzanne George: Yeah, I think you're right. I know that we're getting long, but I just want to say one other thing about that, which is that you're right. If we're bringing patients in to be partners, then we have to treat each other that way. We have to acknowledge- I think this issue that you raise about compensation and about paying people for their time or acknowledging people for their time, I think that's really important and very under-discussed. Liz and I were at the annual meeting for the PE-CGS and someone was there giving a talk about- this was a guest speaker that was giving a talk about a very large high impact grant and that included a patient advocacy kind of module, let's say. And they put in a specific funding and budget for that component that included compensation for the people- from the people in the advocacy community that were spending their time. And the PI of this project, again, not to get into the details of it, but they were sharing that they got a fair bit of pushback on that. But the PI pushed back and said, “Listen, we're compensating other people for their time. These guys, we want them to be partners, we need to treat them as such.” And I think that also again, kind of we're in a new space, but if we're going to do it right, then we have to acknowledge that we're partners. Dr. Davide Soldato: But I think that maybe an experience like the PE-CGS probably can be also a network for expanding awareness for patient advocates and also for creating sort of a new culture about what does that mean and how can we also improve on that part. Because in the end, if we want to engage, we also need to provide patients with the instruments to engage in a way that we think it's both useful for them, that can make research better, but can also make them at the exact same level as everyone who is participating in that research, which I think it's the bottom line of all the concepts that we are discussing right now. Liz Salmi: Yep. Dr. Suzanne George: Yes, I agree. Dr. Davide Soldato: So I think we have covered a lot of things. Just wanted to make one last reference to a point that Suzanne mentioned earlier, which is the interoperability of systems. And I think that when we come to the cancer genome, that is very important, being able to share information, especially for those diverse and less common cancer types that we were discussing earlier. There is a lot of work in gaining all that information and we need to be able to gather all of that information in the same place to advance research. You were mentioning before that the process is actually very complicated and I was wondering if in the network you are already working on some potential ways to address this type of issue. Dr. Suzanne George: I think our first step is really just calling it out, acknowledging how hard this is and what the barriers are. Oftentimes I think in research, we don't talk enough about what our methodologic barriers are. We talk more about what our results are, but not like how hard it is. But like in our projects, the Count Me In project, my network that I'm involved with, we're doing rare tumors. We can only do the United States and Canada because of privacy issues. And we're doing a completely web based platform. So we have the technology. But the privacy laws are impeding our ability to involve other parts of the world. And even within the United States, it's not as easy as we would like to get records. For example, despite the fact that people are saying, “Yes, use my records.” But then it's like, “Okay. Well, that's not that easy. How are we going to get them?” We had to hire a third party vendor in order to get the records, in order to manage all the different consents and releases that were needed across all these different hospital systems. So I think the first question is just calling it out and then from there working together as a community to try to see what the solutions can be, because we need to come up with those solutions. Liz Salmi: Yeah, we're in the same camp as Dr. George and the fact that of the five partners, we're not associated with one particular institution. So we can reach out around the country and get access to those records. And we need them at multiple points in time, over time and it takes a lot of effort and work. And it's not like you could just, say, call hospital A and they have all the information. It's like all of the calls to all of the other sites. And it's not just from one surgery, it's from two or more surgeries. But also the way that people stay involved, and, by people, I mean patients and family members, there's this promise that at some point you're going to get some sort of information in response. Like, it's the “what's in it for me?” aspect of it. We do interviews with those who've been enrolled in the study, those who could be potential enrollees in the future because they've only had one surgery. And what we're learning overall is there's this altruistic nature that people have of- they want to participate in the research because they're like, “Here's my horrible cancer experience. I know other people are going to go through this as well.” There's this guiding light of “I want to do something, and I'm not going to be the person that creates the cure, discovers the genome or whatever for this particular cancer type. But my little bit of participation in this multiplied by 20, 30, 100, 1000 people, is what is going to lead us to the next phase in development and is going to move the needle for this particular tumor type or other cancer types.” And so what I think the impact in this space and participant engagement isn't just something we figure out, like a little research method and a little finding for one small tumor type, it's like the methods to do that is the big impact. The method around participant engagement can impact even beyond the cancer community. Dr. Davide Soldato: Yeah. As Suzanne was saying, we need to be in a system that really helps us and allows us to do that. So I think that you really have a lot of things to work on inside of the network. Dr. Suzanne George: I think one thing that I would say is I think that this issue of interoperability is acknowledged as a challenge. We refer to several different initiatives across the US where this is supposed to ideally change over time. I think people want it to change over time. I think investigators at the ERTC want it to change over time. I think different countries are working on this. And I think, again, the first step is getting us at the table talking about it, and then figuring out ways to move it forward. And I think it's there. I think that there is the will. We just have to figure out the how and continue to work on that together, because there's just a tremendous opportunity. I live in the rare tumor space, and between the FDA and the EMA and the regulatory, the national and the international research groups, the patient communities, people want this to be solved and I do hope that we will be able to get there. Dr. Davide Soldato: So I would like to thank Liz and Suzanne for joining us today. Dr. Suzanne George: Thanks for having us. Liz Salmi: Thank you. Dr. Davide Soldato: Suzanne, Liz, we appreciate you sharing more on your JCO article titled, “Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality.” If you enjoy our show, please leave us a rating and a review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcasts.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.     DISCLOSURES Liz Salmi Speaking Honoria: Medscape. Research Funding (Inst): Abridge AI, Inc., Yosemite. Dr. Suzanne George Honoraria CStone Pharmaceuticals Consulting or Advisory Role Blueprint Medicines, deciphera, Bayer,  Lilly, UpToDate, Research to Practice, MORE Health, Daiichi, Kayothera, Immunicum, BioAtla   Research Funding Blueprint Medicines, Deciphera, Daiichi Sankyo RD Novare, Merck, Eisai, SpringWorks Therapeutics, TRACON Pharma, Theseus Pharmaceuticals, BioAtla, IDRx, NewBay Pharma, Acrivon Therapeutics   Patents, Royalties, Other Intellectual Property Company name: UptoDate Stock and Other Ownership Interests Abbott Laboratories and Pfizer Recipient: An Immediate Family Member

In this episode, Professor Rory O'Connor and Craig spoke to psychiatrist, and Director of the Division of Digital Psychiatry at Beth Israel Deaconess Medical Center, Dr John Torous. John is active in investigating the potential of using mobile mental health technologies for psychiatry, using his expertise to support mindapps.org in building the largest database of mental health apps. As a leader in the field of digital mental health, John has published over 200 peer-reviewed articles and 5 book chapters on the topic. In this conversation, they discussed the impact of technology on mental health, whether mental health apps can aid the diagnosis process, and how to make mental health technology more accessible.

Send us a textIn this episode, Ben and Daphna speak with Dr. Stephen Pearlman, Clinical Effectiveness Officer at ChristianaCare and Professor of Pediatrics at Thomas Jefferson University, and Dr. Munish Gupta, Director of Quality Improvement in Neonatology at Beth Israel Deaconess Medical Center and Assistant Professor at Harvard. Together, they reflect on leading the Quality Improvement (QI) Day at Hot Topics in Neonatology. They discuss integrating data, AI, and family-centered care into QI, practical strategies for engaging teams, and the importance of collaboration and international perspectives in neonatal QI. This conversation highlights actionable insights to improve neonatal care.As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Method for FFPE Organ-Chip -Lindsay Parmelee HTL(ASCP) 1,2,3, Stephanie Pei Tung Yiu PhD 1,2,3,4, Chi Ngai Chan PhD 1,2,3, Sizun Jiang PhD 1,2,31 Center for Virology and Vaccine Research 2 Beth Israel Deaconess Medical Center 3 Harvard Medical School 4 Wyss Institute Organoids are currently being developed for applications in biomedicine such as drug development and disease research. With many organoid models emerging on the market there is growing need to develop methods to adapt organoids to the established work flows and assays that are the foundations of modern research.  A method was developed for processing, embedding, and sectioning Organ-Chips for FFPE workflows. Organ-Chips were treated with Histogel and trimmed to fit standard sized cassettes. Followed by processing and embedding as usual before proceeding to the microtome. The resulting slides have successfully been stained with hematoxylin and eosin and immunohistochemistry, as well as shown promising results for use on multiplexing platforms. Although the process is laborious and requires continued refinement the slides should be sufficient for highplex proteomics and transcriptomics methods and can be used in addition to FFPE tissues for research into immunology, oncology, and virology.

In this episode, UBC Medicine student Monica Hsu sits down with Dr. Anthony Leo Celi, a physician-scientist at Beth Israel Deaconess Medical Center and MIT, to discuss the transformative potential of AI in healthcare. Dr. Celi emphasizes the need for inclusive, representative data to create accurate medical knowledge and algorithms. He advocates for a collaborative approach involving diverse disciplines and citizens to develop AI that addresses health disparities. Dr. Celi stresses the importance of task shifting and redesigning clinical workflows to improve healthcare efficiency and outcomes. Host and Editor: Monica Hsu Music: Dr. Ian Downie New episodes of MEDamorphosis will be available each month. Please rate, review, and subscribe to our podcast and explore the entire UBC Medicine Learning Network roster of podcasts on Spotify, Apple Podcasts, and where you find your podcasts. (C) UBC Medicine Learning Network. All Rights Reserved.

This week, President-elect Donald Trump picked Brendan Carr to be the next chairman of the F.C.C. We talk with The Verge's editor in chief, Nilay Patel, about what this could mean for the future of the internet, and for free speech at large. Then, a new study found that ChatGPT defeated doctors at diagnosing some diseases. One of the study's authors, Dr. Adam Rodman, joins us to discuss the future of medicine. And finally, court is back in session. It's time for the Hard Fork Crimes Division. One more thing: We want to learn more about you, our listeners. Please fill out our quick survey: nytimes.com/hardforksurvey. Guests:Nilay Patel, co-founder of The Verge and host of the podcasts Decoder and The Vergecast.Adam Rodman, internal medicine physician at Beth Israel Deaconess Medical Center and one of the co-authors of a recent study testing the effectiveness of ChatGPT to diagnose illnesses. Additional Reading:Trump Picks Brendan Carr to Lead F.C.C.A.I. Chatbots Defeated Doctors at Diagnosing IllnessGary Wang, a Top FTX Executive, Is Given No Prison Time We want to hear from you. Email us at hardfork@nytimes.com. Find “Hard Fork” on YouTube and TikTok. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

Alice D. Domar, Ph.D. Hands down the most experienced and published mind in the field of reproductive psychology. This interview will introduce you to Dr Domar and her long standing dedication to influencing the reproductive health field and its need to integrate psychological care as standard practice in conventional fertility care and IVF.  So much valuable information tucked into this podcast, but she does boil it all down to 4 main recommendations… Do not suffer in silence, seek out mental health care Don't expect your partner to feel the same way you do Your relationship with your REI is important, switch doctors if necessary You do not have to go to that baby shower ABOUT DR. ‘ALI' DOMAR Dr. Domar is a health psychologist 1987 who focuses on the application of mind/body medicine to women's health issues. Her plethora of research focuses on the relationship between stress and infertility, with a focus on the impact of cognitive behavioral interventions as well as access to care and patient retention. Alice “Ali” Domar, Ph.D., joined Inception Fertility in 2022 as Chief Compassion Officer. She is also a senior staff psychologist in the department of obstetrics and gynecology at Beth Israel Deaconess Medical Center and an associate professor of obstetrics, gynecology, and reproductive biology at Harvard Medical School.  Dr. Domar is on the board for Parents Magazine and served 10 years on the board of Resolve, the National Infertility Association. She is the author of eight books, including Conquering Infertility and Patient-Centered Assisted Reproduction: How to Integrate Exceptional Care with Cutting Edge Technology, and is the co-creator of the apps FertiCalm and FertiStrong. She is a former chair ASRM's mental health professionals group. RESOURCES / REFERENCES HARVARD CV  [https://connects.catalyst.harvard.edu/Profiles/display/Person/28392] - This includes a listing of all the research discussed & published by Dr. Domar.   INCEPTION [https://inceptionfertility.com/] - a network of brands that touches every stage of the fertility lifecycle (IVF centres, research, tech, financing, egg bank, cryo, Rx, supplements) PRELUDE NETWORK [https://www.preludefertility.com/dr-alice-domar] - Subsidiary of Inception, network of fertility centres in N America (offer compassionate care at every step of the patient journey) PACIFIC CENTRE for REPRODUCTIVE MEDICINE [https://www.pacificfertility.ca] - Dr. Jon Havelock and his team at PCRM (Vancouver, Victoria, Edmonton) are members of the Prelude Network.  CONQUERING INFERTILITY [https://a.co/d/dmzUCjP] - Dr Domar's landmark book, revised edition published January 2025.  OTO STRESS / FERTILITY RESEARCH [https://fertilitystudies.com/oto/] - OTO and Inception Fertility (Dr Domar) and its family of brands, including The Prelude Network®, are partnering in a research study investigating the impact (if any) stress has on IVF cycle outcomes. ----- #mentalhealth #ivf #infertility  Podcast Website page -  ----- For more Episodes & Videos visit The Conception Channel - https://www.youtube.com/@TheConceptionChannel YOU CAN ALSO LISTEN AND SUBSCRIBE TO THE CONCEPTION CHANNEL PODCAST ON ALL YOUR FAVOURITE PODCAST PLATFORMS. ----- CONNECT WITH DR PENTLAND Private practice: https://drspencepentland.com/ Fertility Clinics: https://yinstill.com/

Today, we're excited to get to know Dr. Muthu Alagappan, CEO and Founder of Counsel, the modern solution for access to care. Before founding Counsel, Muthu was the CMO of Notable Health for almost 4 years and was an Attending Physician at Beth Israel Deaconess Medical Center and UCSF Medical Center. He graduated with his MD from Stanford Medicine and (fun fact!) was also the Student Commencement Speaker for his graduating class.Founded in 2023, Counsel provides patients with high-quality, personalized medical advice from expert doctors within minutes. Counsel recently announced $11M in seed funding from investors like A16z, Floodgate, Asymmetric Capital and Pear VC! We're proud to be partners to Counsel!

Curious about how cosmetic surgery can restore confidence during midlife? In this episode, we uncover the most popular procedures and what they can do for women navigating the changes of menopause and beyond.Dr. Sameena Rahman welcomes her longtime friend and renowned plastic surgeon, Dr. Azra Ashraf, for an insightful conversation about cosmetic surgery for midlife women. Dr. Ashraf shares her journey as a surgeon and discusses the most common procedures sought by women in their 40s and 50s, from breast lifts to tummy tucks and facial rejuvenation. Together, they explore how hormonal changes, such as the loss of estrogen, impact the body and why cosmetic surgery can often help women feel more like themselves again.They also talk about the importance of reconstructive procedures for women undergoing mastectomies, including breast reconstruction options that have transformed recovery for cancer survivors. Dr. Ashraf shares her personal experiences of helping women regain their confidence and improve their quality of life.Episode Highlights:The rise in cosmetic procedures among perimenopausal women.Breast lifts, tummy tucks, and liposuction as part of the "mommy makeover."How hormonal changes during menopause affect body shape.The importance of breast reconstruction for women post-mastectomy.Why some cosmetic procedures are shifting toward more natural, proportioned results.Don't forget to subscribe, rate, and review the podcast on your favorite platform! Share this episode with friends who might benefit from learning more about midlife cosmetic procedures and recovery options.Dr. Ashraf's Bio:Dr. Azra Ashraf is a double Board-Certified Plastic Surgeon, boarded by the American Board of Plastic Surgery and American Board of Surgery. She has worked on east and west coasts with over 10 years of cosmetic surgery expertise. Dr. Ashraf was a recognized physician in the Washington DC area, voted a Top Doctor. She is a Californian at heart and loves practicing in her home state.Dr. Ashraf completed a BA in Public Policy from Brown University, focusing on gender equity in healthcare. This led her to pursue an MPH from Harvard School of Public Health while jointly attending Brown Medical School. She has always loved working with her hands, and knew she wanted to pursue surgery as soon as she started medical school. She is a highly skilled surgeon with an artistic eye for detail.She trained in general surgery at Saint Elizabeth Medical Center (Boston, MA), an affiliate of Tufts Medical School. She completed her plastic surgery training at Temple University Hospital (Philadelphia, PA). Dr. Ashraf has distinguished herself by completing an additional year in comprehensive breast reconstruction, including microvascular and aesthetic breast surgeries at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School.She is recognized as a beauty expert by both the community and media. Schedule a consultation and work with Dr. Ashraf to diversify the idea of beauty.Get in touch with Dr. Ashraf:WebsiteInstagramGet in Touch with Dr. Rahman:WebsiteInstagramYoutube

In this special episode, RAPM Focus takes a break from its usual format of discussing specific research projects to discuss instead how research in health care is increasingly vital yet often hindered by escalating costs and time constraints. Editor-in-Chief Brian Sites, MD, discusses these challenges with Alexander (Xan) Abess, MD, and Jonathan Weed, MD. Traditional, large scale, randomized controlled trials are resource intensive, making them challenging for clinicians to conduct. As a result, innovative approaches to engage in knowledge acquisition are becoming paramount. Creating a scholastic environment within the anesthesia department not only fosters a culture of continuous learning, but also becomes essential for attracting and retaining talent. Dr. Abess is an anesthesiologist at Dartmouth Hitchcock Medical Center and assistant professor of anesthesiology and perioperative medicine at Geisel School of Medicine at Dartmouth. He has previously served as the vice chair of quality and safety, department of anesthesiology and perioperative medicine, and is actively involved with the Multi-Center Perioperative Outcomes Group (MPOG). He is the founder and Director of IDEA Lab (Innovation, Development, and Entrepreneurship in Anesthesiology). Xan has a wide range of clinical experience (private practice, academic medicine, military medicine) and medical device development experience, having previously started his own medical device company. He understands well the challenges of medical innovation and truly enjoys helping others achieve their development goals while also attempting to improve the quality of health care delivery and simultaneously addressing our broader economic and workforce challenges. Dr. Weed is a clinical assistant professor of anesthesiology at Dartmouth Hitchcock Medical Center. He is a graduate of Tulane Medical School and completed his anesthesiology residency at Beth Israel Deaconess Medical Center, followed by a fellowship at Dartmouth Hitchcock Medical Center in regional anesthesia. He spent several years as a residency program director at Tulane Medical Center before returning to Tulane Medical Center in 2021. His most recent interests relate to the use of the electronic health record to improve clinical workflow in research within the department. *The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a health care practitioner's judgment, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others. Podcast and music produced by Dan Langa. Find us on X @RAPMOnline, Facebook @Regional Anesthesia & Pain Medicine, and Instagram @RAPM_Online.

In this episode of the MPFI Neurotransmissions Podcast, we sit down with Dr. Mark Andermann (@AndermannLab), a renowned neuroscientist at Beth Israel Deaconess Medical Center & Harvard University, to explore the intricate neural circuits that regulate feeding behavior. Dr. Andermann shares his groundbreaking research on how the brain processes hunger and satiety signals, and what happens when these systems go awry in cases of dysfunctional eating. Episode Guest: Mark Andermann - @AndermannLab Andermann Lab: https://www.andermannlab.com/ Episode Hosts: Akash Pal- @pal116a Lesley Colgan - @Colgan_Lesley Podcast episode produced and edited by Kevin Guy Albertini - @KGAlbertini Do you enjoy the podcast? Feel free to like this episode and follow us to hear more episodes! Max Planck Florida's Neurotransmissions Podcast Website: https://www.mpfi.org/news-media/podcast Social Media: @MPFneuro Twitter: / mpfneuro Instagram: / mpfneuro Facebook: / mpfneuro

In this episode, we discuss the science around what some call leaky gut syndrome and get an evidence-based understanding of why “leaky gut” is a colloquial term that refers to increased intestinal permeability, which causes or occurs in some gastrointestinal conditions. This episode features Dr. Trisha Pasricha, a gastroenterologist at Beth Israel Deaconess Medical Center and an instructor of medicine at Harvard Medical School whose work has been featured in The New York Times, The Washington Post and The Atlantic. Dr. Pasricha provides expert insight on the differences between what is conveyed on social media about leaky gut, versus how the medical community views leaky gut, and whether or not leaky gut syndrome is even a recognized medical condition in gastroenterology. This episode is brought to in partnership with The American College of Gastroenterology's Patient Care Committee.  

In this episode, podcast hosts Dr. Josh Roshal, Dr. Darian Hoagland, and Dr. Maya Hunt dive into two important papers that provide guidance on navigating the hidden curriculum of the surgical residency match process. Joined by fellow CoSEF members Dr. Ariana Naaseh and Dr. John Woodward, the discussion revolves around practical tips for finding your perfect surgical residency and filtering out the noise during the application process. Journal Club Hosts: –Dr. Josh Roshal, University of Texas Medical Branch, @Joshua_Roshal, jaroshal@utmb.edu –Dr. Darian Hoagland, Beth Israel Deaconess Medical Center, @DHoaglandMD, dlhoagla@bidmc.harvard.edu –Dr. Maya Hunt, Indiana University, @dr_mayathehunt, mayahunt@iu.edu –CoSEF: @surgedfellows, cosef.org Journal Club Authors:  -Dr. Ariana Naaseh, Washington University in St. Louis, @ariananaaseh, a.naaseh@wustl.edu -Dr. John Woodwad, University at Buffalo, @JohnWoodward76, jmwoodwa@buffalo.edu Medical Students:  -Rachel Kalbfell (MS4), Washington University in St. Louis, @rachelkalbfell,  rkalbfell@wustl.edu -Keith Makhecha (MS4), Indiana University, kmakhech@iu.edu References: 1.    Woodward JM, Lund S, Brian R, Anand A, Moreci R, Navarro SM, Zarate Rodriguez J, Naaseh A, Tate K, Roshal J, Silvestri C, Gan CY, Sathe T, Thornton SW, Cloonan M, Weaver L, Oh MH, Godley F, L'Huillier JC. Find Your Perfect Match for Surgical Residency: Six Steps to Building Your BRANDD from the Collaboration of Surgical Education Fellows. Annals of Surgery. 2024;5(3). doi:10.1097/AS9.0000000000000466. 2.    Naaseh A, Roshal J, Silvestri C, Woodward JM, Thornton SW, L'Huillier JC, Hunt M, Sathe TS, Hoagland DL, Godley F IV, Jindani R, Tieken KR, Rodriguez JGZ, Anand A, Chen JH, Navarro SM, Lund S. Filter Out the Noise: How to Narrow Your Search for the Perfect Match by the Collaboration of Surgical Education Fellows (CoSEF). Journal of Surgical Education. 2024;81(10):1394-1399. doi:10.1016/j.jsurg.2024.07.010 https://pubmed.ncbi.nlm.nih.gov/39178489/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

Are we prepared to face another devastating pandemic in the coming years? What leads to global pandemics such as COVID-19? In this fascinating conversation, Dr. Emeran Mayer, Founding Director of the UCLA Brain-Gut Microbiome Center, explores with Sadhguru, some of these questions and delves into foods that are supportive for our gut microbiome and overall health. The discussion is part of the Science and Spirituality series, hosted by the Sadhguru Center for a Conscious Planet, Beth Israel Deaconess Medical Center. Can sexuality be used as a means to reach one's ultimate nature? Sadhguru addresses this frequently asked question and provides insight into the true nature of sexuality. Conscious Planet: https://www.consciousplanet.org Sadhguru App (Download): https://onelink.to/sadhguru__app Official Sadhguru Website: https://isha.sadhguru.org Sadhguru Exclusive: https://isha.sadhguru.org/in/en/sadhguru-exclusive Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

Are we prepared to face another devastating pandemic in the coming years? What leads to global pandemics such as COVID-19? In this fascinating conversation, Dr. Emeran Mayer, Founding Director of the UCLA Brain-Gut Microbiome Center, explores with Sadhguru, some of these questions and delves into foods that are supportive for our gut microbiome and overall health. The discussion is part of the Science and Spirituality series, hosted by the Sadhguru Center for a Conscious Planet, Beth Israel Deaconess Medical Center. Can sexuality be used as a means to reach one's ultimate nature? Sadhguru addresses this frequently asked question and provides insight into the true nature of sexuality. Conscious Planet: https://www.consciousplanet.org Sadhguru App (Download): https://onelink.to/sadhguru__app Official Sadhguru Website: https://isha.sadhguru.org Sadhguru Exclusive: https://isha.sadhguru.org/in/en/sadhguru-exclusive Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

We kicked off the program with four news stories and different guests on the stories we think you need to know about! Sen. Bruce Tarr joined us to discuss the recent passage of H.4915, An Act relative to the use of elephants, big cats, primates, giraffes and bears in traveling exhibits and shows.Timothy Malcolm, Author of MOON BASEBALL ROAD TRIPS - The Complete Guide to All The Ballparks, With Beer, Bites, and Sights Nearby checked in.Javier Perez – Attorney shared his thoughts on a survey: 40% of Gen Z workers are willing to quit job over political differences with their boss.Jeff Hall – Communications Manager of American Red Cross talked about how the Boston Red Sox & Beth Israel Deaconess Medical Center team up for the Day of Remembrance Blood Drive at Fenway Park.Ask Alexa to play WBZ NewsRadio on #iHeartRadio!

Dr. Paul Sue is an associate professor of pediatrics at the Columbia University and Director of the Pediatric Transplant and Immunocompromised Host or “PITCH” Infectious Diseases Program at the Morgan Stanley Children's Hospital in NY.  He completed his pediatric residency at Jacobi Medical Center at the Albert Einstein College of Medicine in the Bronx, and his fellowship in pediatric infectious diseases at Johns Hopkins University in Baltimore. He then moved to UT Southwestern in Dallas TX, where he served as director of Pediatric ICH ID service for the next 8 years, prior to his recent move back to NY.  His research interests include the impact of invasive fungal and viral infections in the immunocompromised host,  leveraging measures of functional immunity to improve infectious disease outcomes in high-risk patients,  and the emergence of community acquired multidrug resistant (MDR) bacterial infections in immunocompromised children. Sara Dong, MD is an adult and pediatric infectious disease physician at Emory University School of Medicine & Children's Healthcare of Atlanta, where her clinical focus is transplant and immunocompromised host ID.  She earned her MD from the Medical University of South Carolina.  She completed her internal medicine and pediatrics (Med-Peds) residency and chief residency years at Ohio State University Wexner Medical Center and Nationwide Children's Hospital, followed by Med-Peds ID and Medical Education fellowships at Beth Israel Deaconess Medical Center and Boston Children's Hospital.  She is the creator and host of Febrile podcast and learning platform, co-host of the ID Puscast podcast, and the program director for the ID Digital Institute.Learning ObjectivesAfter listening to this episode on invasive candidemia, learners should be able to discuss:Treatment of candidemia in a critically-ill immunocompromised patient.Management of indwelling central catheters in critically-ill patients with candidemia.The role of immune adjuncts (e.g. G-CSF or granulocyte transfusions) in the management of persistent candidemia in an immunocompromised patient.References:https://febrilepodcast.com/ Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update bQuestions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the Show.How to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

In this episode, Dr. Stuart Slavin interviews Dr. Jim Naples, an assistant professor of otolaryngology at Harvard Medical School and residency director at Beth Israel Deaconess Medical Center. They discuss the challenges of transitioning from medical school to residency, focusing on Dr. Naples' personal struggles with the “surgical yips” during his education and training. He describes the anxiety and pressure of being closely monitored in the operating room, which exacerbated his difficulties. Dr. Naples emphasizes the impact of the high-pressure environment on his performance and the importance of addressing these challenges in medical education.

  Dr. Meyerhardt is the Chief Clinical Officer for Dana-Farber and Co-Director of the Colon and Rectal Cancer Center as a medical oncologist specializing in cancers in the GI tract. He is also the Douglas Gray Woodruff Chair in Colorectal Cancer Research and a Professor of Medicine at Harvard Medical School.       Dr. Meyerhardt received his MD from Yale School of Medicine in 1997. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, in Boston, followed by a medical oncology fellowship at DFCI. He joined the Gastrointestinal Cancer Center at Dana-Farber in 2002.

Dr. Paul Sue is an associate professor of pediatrics at the Columbia University and Director of the Pediatric Transplant and Immunocompromised Host at the Morgan Stanley Children's Hospital in NY.  He completed his pediatric residency at Jacobi Medical Center at the Albert Einstein College of Medicine in the Bronx, and his fellowship in pediatric infectious diseases at Johns Hopkins University in Baltimore. He then moved to UT Southwestern in Dallas TX, where he served as director of Pediatric ICH ID service for the next 8 years, prior to his recent move back to NY.  His research interests include the impact of invasive fungal and viral infections in the immunocompromised host,  leveraging measures of functional immunity to improve infectious disease outcomes in high-risk patients,  and the emergence of community acquired multidrug resistant (MDR) bacterial infections in immunocompromised children. Sara Dong, MD is an adult and pediatric infectious disease physician at Emory University School of Medicine & Children's Healthcare of Atlanta, where her clinical focus is transplant and immunocompromised host ID.  She earned her MD from the Medical University of South Carolina.  She completed her internal medicine and pediatrics (Med-Peds) residency and chief residency years at Ohio State University Wexner Medical Center and Nationwide Children's Hospital, followed by Med-Peds ID and Medical Education fellowships at Beth Israel Deaconess Medical Center and Boston Children's Hospital.  She is the creator and host of Febrile podcast and learning platform, co-host of the ID Puscast podcast, and the program director for the ID Digital Institute.Learning ObjectivesAfter listening to this episode on invasive candidemia, learners should be able to discuss:Risk factors associated with invasive fungal infections in critically-ill immunocompromised patients.Common pathogens associated with invasive fungal infections in critically-ill immunocompromised patients.Principles guiding selection of empiric antifungal agents for critically-ill patients at risk of invasive fungal infections.References:https://febrilepodcast.com/ Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the InfQuestions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the Show.How to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

The New York Times recently called Ozempic a “new match for menopausal weight gain”. But is it? These drugs can be a godsend for those who need them. But there's a lot we need to understand. How do they work? How well do they work? Who benefits from them? What are their risks? What impact do they have on muscle, bone, and performance? How do they affect training and racing? We dig into all of that and more this week with endocrinologist and Ironman triathlete Dr. Jody Dushay who has been researching these drugs for more than a decade. Jody Dushay, M.D., MMSc, is an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. She is also the founder and director of Well Powered, a comprehensive wellness and weight management program. Dr Dushay has studied the effect of pharmacotherapies and dietary interventions on body weight for years, including a large single-site study examining the effects of a glucagon-like peptide receptor agonist on body weight in obese women without diabetes. As a triathlete, she has qualified for Kona 3 times and came in 2nd in her age group at the 2020 Ironman World Championship in St George. You can learn more about her and her work at wellpowered.org.Resources:Dr. Jody Dushay's research:Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetesWeight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese WomenSubscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page Feisty Menopause Performance Retreat: Join us from November 21st-23rd, 2024 https://www.feistymenopause.com/retreat Join the FREE Women's Sports Fan Club: fanclub.feisty.co Follow Us on Instagram:Feisty Menopause: @feistymenopause Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Join Level Up:https://www.feistymenopause.com/monthly-membership-1 Support our Partners:Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/ Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/ Tifosi Optics: Use code FM20! for 20% off at https://tifosioptics.com/ Lagoon Sleep: Go to LagoonSleep.com/hitplay and take the 2 minute sleep quiz to find your match, and then use the code HITPLAY for 15% off your first purchase This podcast uses the following third-party services for analysis: Podscribe - https://podscribe.com/privacyPodcorn - https://podcorn.com/privacySpotify Ad Analytics - https://www.spotify.com/us/legal/ad-analytics-privacy-policy/Chartable - https://chartable.com/privacy

In this episode, we dive into the world of Integrating the Health Enterprise (IHE) profiles with three key figures who have been instrumental in their development. Join us as we speak with David Kwan, the current IHE Canada chair and an expert in diagnostic imaging and structured reporting; Kinson Ho, a healthcare informatics veteran with over 20 years of experience in system development and architecture; and Dr. Seth Berkowitz, an interventional radiologist and medical director of radiology informatics at Beth Israel Deaconess Medical Center. We explore the creation and implementation of the Interactive Multimedia Reporting (IMR) and Integrated Real-Time Applications (IRA) profiles. Our guests share their journeys, from initial exposure to multimedia reporting concepts to leading the charge in integrating these profiles into real-world applications. The discussion delves into the challenges and successes of standardizing reporting workflows, the role of open-source software in innovation, and the future of imaging diagnostic reports. Visit siim.org for more information and follow us on Twitter at @siim_tweets for updates and educational content.

Renowned cosmologist Prof. Bernard Carr explores the mystery of parallel universes with Sadhguru in a discussion facilitated by Dr. Bala Subramaniam, Professor of Anesthesiology at Harvard Medical School. The event was hosted by the Sadhguru Center for a Conscious Planet at Beth Israel Deaconess Medical Center. Conscious Planet: https://www.consciousplanet.org Sadhguru App (Download): https://onelink.to/sadhguru__app Official Sadhguru Website: https://isha.sadhguru.org Sadhguru Exclusive: https://isha.sadhguru.org/in/en/sadhguru-exclusive Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

Renowned cosmologist Prof. Bernard Carr explores the mystery of parallel universes with Sadhguru in a discussion facilitated by Dr. Bala Subramaniam, Professor of Anesthesiology at Harvard Medical School. The event was hosted by the Sadhguru Center for a Conscious Planet at Beth Israel Deaconess Medical Center. Conscious Planet: https://www.consciousplanet.org Sadhguru App (Download): https://onelink.to/sadhguru__app Official Sadhguru Website: https://isha.sadhguru.org Sadhguru Exclusive: https://isha.sadhguru.org/in/en/sadhguru-exclusive Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

In a world where we're expected to mask our struggles behind a white coat or a suit, finding the courage to be an open book is truly commendable. We all have struggles and setbacks in different forms. Some of us face challenges in our careers, others deal with personal issues, and many of us encounter both at the same time. Whether it's grappling with addiction, experiencing job loss, or dealing with health crises, the journey through these trials can be incredibly tough.    Many of us compartmentalize our pain until it overwhelms us, but acknowledging our challenges is the first step towards healing. When we begin to openly recognize and talk about our difficulties, we take a significant step toward recovery. Embracing this openness allows us to seek the support we need from mentors, coaches, and loved ones. By sharing our experiences and vulnerabilities, we break down the walls of isolation and build connections with others who may have faced similar struggles and provide them with grace we have received.Remember, it's through understanding our struggles and reaching out for support that we transform our challenges into strengths.    Courtney Barrows McKeown, MD is a board-certified general surgeon. She earned her medical degree at New York Medical College, graduating Alpha Omega Alpha. She completed her general surgery residency training in 2020 at Beth Israel Deaconess Medical Center in Boston, MA, and received additional subspecialty training in hepatopancreatobiliary (HPB surgery) in the Midwest. She started her career as a community general surgeon in New Hampshire, and is excited for her next opportunity, where she will be moving to TN to join Dr. Vertrees' Columbia Surgical Partners as a general surgeon. Her mission is to provide hope and mentorship to other early career physicians who may be struggling with similar issues she faced, reduce stigma, and help drive systemic changes in order to make our professional climate better for the next generation of surgeons.   In this episode with Dr. Courtney Barrows McKeown, we will learn about the power of resilience, the importance of seeking help, and the value of mentorship in overcoming personal and professional challenges. Dr. McKeown openly discusses the difficulties of dealing with addiction, especially in a high-pressure profession like surgery. Her honesty about her struggles is both courageous and inspiring, shedding light on the often-hidden challenges faced by many professionals. Dr. McKeown's story is a beacon of hope, showing that with perseverance and the right support, we can overcome even the most daunting obstacles.    "It's not my fault that I have a disease, but it is my responsibility to get it treated and then manage it." –  Dr. Courtney Barrows McKeown   Topics Covered: (00:00:34) Introducing our special guest, Dr. Courtney Barrows McKeown (00:02:56) Hitting rock bottom (00:04:01) How acceptance and accountability change Dr. Courtney for the better (00:06:03) Career opportunity through coaching connections (00:08:52) The silent struggles of medical professionals (00:10:37) The value of coaching for physicians (00:13:00) An overcomer by the grace of God (00:17:12) How Dr. Courtney's med school stress sparked a struggle with addiction (00:21:38) Advertisement: Are you prepared for life's unexpected challenges? Dr. Stephanie Pearson and her team of skilled advisors at Pearson Ravitz are here to help you guard your most valuable asset. Go to https://pearsonravitz.com/ to make sure you are protected today. (00:22:28) Who was able to help you get help?  (00:25:23) How compassion made healing possible (00:27:12) Prevalence of mental health issues in healthcare (00:29:50) Embracing a new beginning (00:34:03) The role of patience and timing in career success (00:37:06) The Final TimeOut: Jeremiah 29:11 (00:39:02) Where to connect to  Dr. Courtney Barrows McKeown (00:21:49)    Key Takeaways:    "The problem with social media and being a doctor is that many times we feel that we have to struggle alone."– Dr. Derrick Burgess   "We've learned to compartmentalize our struggles and show up for everyone else, ignoring our own problems until they come back to destroy us."– Dr. Derrick Burgess   "You are not your struggles, you are not your addiction, you are not whatever you struggled with. It doesn't define you."– Dr. Derrick Burgess   "You do the best you can until you know better, and then when you know better, do better."–  Dr. Courtney Barrows McKeown   "Just like athletes need coaches to perform at their peak ability, anybody else from a lawyer, a physician, we need coaching as well."– Dr. Derrick Burgess   “Having all of those people behind me to help, I can't take much credit honestly, other than just kind of being willing to move forward and not give up.” –  Dr. Courtney Barrows McKeown   “Just because someone shows up to work every day and is able to perform from 6 to 5 or 6 to 9, doesn't mean that they're ok.” – Dr. Derrick Burgess   “It's ok to cry for both good and sad reasons.” –  Dr. Courtney Barrows McKeown   Connect with Dr. Courtney Barrows McKeown: Facebook: https://www.facebook.com/courtney.barrows Instagram: https://www.instagram.com/courtb_mckeown_md LinkedIn: https://www.linkedin.com/in/courtney-barrows-mckeown-md/    Connect with Dr. Derrick Burgess: Website: https://www.drderrickthesportsdr.com/ Instagram: https://www.instagram.com/drderrickthesportsdr/ Facebook: https://www.facebook.com/TimeOut.SportsDr LinkedIn: https://www.linkedin.com/in/derrick-burgess-72047b246/ YouTube: https://www.youtube.com/channel/UCHGDu1zT4K_X6PnYELu8weg Email: thesportsdoctr@gmail.com   This episode of TimeOut with the SportsDr. is produced by Podcast VAs Philippines - the team that helps podcasters effectively launch and manage their podcasts, so we don't have to. Record, share, and repeat! Podcast VAs PH gives me back my time so I can focus on the core functions of my business. Need expert help with your podcast? Go to www.podcastvasph.com.

Explore the fascinating intersection of science and spirituality, in a discussion featuring cosmologist Professor Bernard Carr, neuroscientist Christof Koch, geneticist Dr. Rudy Tanzi, author and speaker Deepak Chopra and Sadhguru as they explore the super brain, epigenetics, consciousness and more, in an event hosted by the Sadhguru Center for a Conscious Planet at Beth Israel Deaconess Medical Center. The discussion was facilitated by Dr. Balachundhar Subramaniam of Harvard Medical School. Conscious Planet: https://www.consciousplanet.org Sadhguru App (Download): https://onelink.to/sadhguru__app Official Sadhguru Website: https://isha.sadhguru.org Sadhguru Exclusive: https://isha.sadhguru.org/in/en/sadhguru-exclusive Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

We continue our Year of the Zebra focus on rare diseases today by exploring the ability of AI technology to aid in the diagnosis of rare and other conditions by analyzing the voice and speech of the patient. This approach is promising enough that the National Institutes of Health has invested in research projects to test its effectiveness, and the private sector is pursuing it as well, including the company Canary Speech whose technology can be trained to detect conditions that are traditionally difficult to identify, or those where early identification is crucial to treatment. “With just seconds of conversational speech, we can screen for multiple behavioral and cognitive conditions,” says Caitlyn Brooksby, Canary's vice president of Marketing and Strategic Partnership. One prime example she offers is a study on Huntington's disease done in collaboration with Beth Israel Deaconess Medical Center in which more than a thousand features of speech were identified differentiating healthy patients from those with the disease. “Every ten seconds, we're looking at millions of data points, but we don't look at the words you say. We're looking at biomarkers within speech such as duration per word, word-per-second, bandwidth and contrast. It's really incredible what we can gather from speech alone,” she explains. Canary is in the second iteration of its Huntington's model which is showing accuracy rates of 90% and above, and it recently added mild cognitive impairment, Alzheimer's, and Parkinson's disease to its offerings. Join host Lindsey Smith on this episode of Raise the Line to learn more about this promising approach to diagnosis.Mentioned in this episode:Canary Speech 

Join Mike Carlozzi and Bill Burke as they discuss leading the EP Lab at Beth Israel Deaconess Medical Center, touching on topics such as building morale, managing staffing issues, and training new team members.

Read the full show notes: https://www.draimee.org/supporting-fertility-with-mind-body-strategies-techniques-with-dr-alice-domar   As you know, I encourage all fertility patients to support themselves throughout their fertility journey from a mind and body perspective. I'm beyond delighted to have Alice D. Domar, Ph.D back on the podcast to talk about how to support fertility with mind/body strategies and techniques. She is currently the Chief Compassion Officer at Inception, an associate professor in obstetrics, gynecology, and reproductive biology, part-time, at Harvard Medical School, and a senior staff psychologist at Beth Israel Deaconess Medical Center.   Dr. Domar established the first ever Mind/Body Center for Women's Health ~ as well as the very first Mind/Body Program for Fertility. She now teaches people strategies to reduce anxiety, depression, and distress through relaxation, mindfulness, cognitive restructuring, and yoga. Research continues to show that mind/body infertility programs not only improves psychological symptoms, but also increases pregnancy rates. We will be talking about all of this, along with her redesigned mobile app FertiCalmPro (which contains more than 500 solutions to the events and situations most likely to cause distress for anyone experiencing infertility), and her new program with Best Shot.    This discussion about the mind/body connection is so very important, because the mental and emotional strain on fertility patients is something that doesn't get enough attention. Be sure and check out Dr. Domar's books and resources for more information. Read the full show notes on Dr. Aimee's website Visit Dr. Domar's site to find her books and programs.   Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class.  The next live class call is on Monday, July 17, 2024 at 4pm PST, where Dr. Aimee will explain Egg Freezing and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates

CardioNerds join Dr. Inbar Raber and Dr. Susan Mcilvaine from the Beth Israel Deaconess Medical Center for a Fenway game. They discuss the following case: A 72-year-old man presents with two weeks of progressive dyspnea, orthopnea, nausea, vomiting, diarrhea, and right upper quadrant pain. He has a history of essential thrombocytosis, Barrett's esophagus, basal cell skin cancer, and hypertension treated with hydralazine. He is found to have bilateral pleural effusions and a pericardial effusion. He undergoes a work-up, including pericardial cytology, which is negative, and blood tests reveal a positive ANA and positive anti-histone antibody. He is diagnosed with drug-induced lupus due to hydralazine and starts treatment with intravenous steroids, resulting in an improvement in his symptoms. Expert commentary is provided by UT Southwestern internal medicine residency program director Dr. Salahuddin (“Dino”) Kazi. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media Pearls - A Drug's Adverse Effect Unleashes the Wolf The differential diagnosis for pericardial effusion includes metabolic, malignant, medication-induced, traumatic, rheumatologic, and infectious etiologies. While pericardial cytology can aid in securing a diagnosis of cancer in patients with malignant pericardial effusions, the sensitivity of the test is limited at around 50%.  Common symptoms of drug-induced lupus include fever, arthralgias, myalgias, rash, and/or serositis. Anti-histone antibodies are typically present in drug-induced lupus, while anti-dsDNA antibodies are typically absent (unlike in systemic lupus erythematosus, SLE). Hydralazine-induced lupus has a prevalence of 5-10%, with a higher risk for patients on higher doses or longer durations of drug exposure. Onset is usually months to years after drug initiation. Show Notes - A Drug's Adverse Effect Unleashes the Wolf There is a broad differential diagnosis for pericardial effusion which includes metabolic, malignant, medication-induced, traumatic, rheumatologic, and infectious etiologies. Metabolic etiologies include renal failure and thyroid disease. Certain malignancies are more likely to cause pericardial effusions, including lung cancer, lymphoma, breast cancer, sarcoma, and melanoma. Radiation therapy to treat chest malignancies can also result in a pericardial effusion. Medications can cause pericardial effusion, including immune checkpoint inhibitors, which can cause myocarditis or pericarditis, and medications associated with drug-induced lupus, such as procainamide, hydralazine, phenytoin, minoxidil, or isoniazid. Trauma can cause pericardial effusions, including blunt chest trauma, cardiac surgery, or cardiac catheterization. Rheumatologic etiologies include lupus, rheumatoid arthritis, systemic sclerosis, sarcoid, and vasculitis. Many different types of infections can cause pericardial effusions, including viruses (e.g., coxsackievirus, echovirus, adenovirus, human immunodeficiency virus, and influenza), bacteria (TB, staphylococcus, streptococcus, and pneumococcus), and fungi. Other must-not-miss etiologies include emergencies like type A aortic dissection and myocardial infarction. In a retrospective study of all patients who presented with a hemodynamically significant pericardial effusion and underwent pericardiocentesis, 33% of patients were found to have an underlying malignancy(Ben-Horin et al). Bloody effusion and frank tamponade were significantly more common among patients with malignant effusion, but the overlap was significant, and no epidemiologic or clinical parameter was found useful to differentiate between cancerous and noncancerous effus...

Dr. Emeran Mayer, Founding Director of the UCLA Brain-Gut Microbiome Center, engages in a captivating conversation with Sadhguru about the gut microbiome, its connection to human health, and foods that are supportive for health and the enhancement of one's perception. Moderated by Dr. Bala Subramaniam, Professor of Anesthesiology at Harvard Medical School, the discussion is part of the Science and Spirituality series, hosted by the Sadhguru Center for a Conscious Planet, Beth Israel Deaconess Medical Center. Conscious Planet: https://www.consciousplanet.org Sadhguru App (Download): https://onelink.to/sadhguru__app Official Sadhguru Website: https://isha.sadhguru.org Sadhguru Exclusive: https://isha.sadhguru.org/in/en/sadhguru-exclusive Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times.